Print Friendly, PDF & Email

NCT/Study#

NCT04116437 /

BGB-3111-215

A Phase 2, Multicenter, Single-Arm Study Of Zanubrutinib (BGB-3111) In Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant Of Prior Treatment With Ibrutinib

DISEASE GROUP:
Lymphoma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: